274 related articles for article (PubMed ID: 16581113)
1. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
[TBL] [Abstract][Full Text] [Related]
2. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
3. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
[TBL] [Abstract][Full Text] [Related]
4. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
[TBL] [Abstract][Full Text] [Related]
5. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
[TBL] [Abstract][Full Text] [Related]
6. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
Lacy GL; Adams DM; Hellstrom WJ
Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
[TBL] [Abstract][Full Text] [Related]
7. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease.
Dang G; Matern R; Bivalacqua TJ; Sikka S; Hellstrom WJ
South Med J; 2004 Jan; 97(1):42-6. PubMed ID: 14746421
[TBL] [Abstract][Full Text] [Related]
8. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Management of Peyronie's Disease.
Trost LW; Gur S; Hellstrom WJ
Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
[TBL] [Abstract][Full Text] [Related]
10. Medical management of Peyronie's disease.
Hellstrom WJ
J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Peyronie's disease with local interferon-alpha 2b.
Brake M; Loertzer H; Horsch R; Keller H
BJU Int; 2001 May; 87(7):654-7. PubMed ID: 11350406
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
[TBL] [Abstract][Full Text] [Related]
13. Intralesional recombinant interferon alpha-2b in Peyronie's disease.
Astorga R; Cantero O; Contreras D; del Río-Martín A; Labarta-Beceiro V; Gutiérrez-Elvírez A; Lima-López MA; López-Saura P
Arch Esp Urol; 2000 Sep; 53(7):665-71. PubMed ID: 11037665
[TBL] [Abstract][Full Text] [Related]
14. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
Judge IS; Wisniewski ZS
Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
[TBL] [Abstract][Full Text] [Related]
16. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease.
Wegner HE; Andresen R; Knispel HH; Miller K
Eur Urol; 1997; 32(2):190-3. PubMed ID: 9286652
[TBL] [Abstract][Full Text] [Related]
17. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
Jordan GH
J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease.
Yafi FA; Pinsky MR; Stewart C; Sangkum P; Ates E; Trost LW; Sikka SC; Hellstrom WJ
J Urol; 2015 Sep; 194(3):754-8. PubMed ID: 25804087
[TBL] [Abstract][Full Text] [Related]
19. Management of Peyronie's disease--a review.
Tunuguntla HS
World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
[TBL] [Abstract][Full Text] [Related]
20. Peyronie's disease: review and recent advances.
Langston JP; Carson CC
Maturitas; 2014 Aug; 78(4):341-3. PubMed ID: 24984940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
